BRASART HCT 160 MG + 12,5 MG COM REV CT BL AL AL X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1356907320147 -
GGREM
531620050087607 -
Código de barras
7894916508353
O que a fonte publica
- Detentor do registro
- EMS SIGMA PHARMA LTDA
- Princípios ativos
- HIDROCLOROTIAZIDA;VALSARTANA
- Embalagem
- 160 MG + 12,5 MG COM REV CT BL AL AL X 30
- Tipo de produto
- Similar
- Classe terapêutica
- C9D1 - ANTAGONISTAS DA ANGIOTENSINA II ASSOCIADOS A ANTIHIPERTENSIVOS (C2) E/OU DIURÉTICOS
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "BRASART HCT 160 MG + 12,5 MG COM REV CT BL AL AL X 30",
"holder": "EMS SIGMA PHARMA LTDA",
"stripe": null,
"barcodes": [
"7894916508353"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "531620050087607",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "00.923.140/0001-31",
"priceRegime": "Regulado",
"productName": "BRASART HCT",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "160 MG + 12,5 MG COM REV CT BL AL AL X 30",
"sourceStatus": null,
"supplyRegime": null,
"factoryPrices": {
"icms-0": "150.32",
"icms-12": "170.82",
"icms-17": "181.11",
"icms-18": "183.32",
"icms-19": "185.58",
"icms-20": "187.90",
"icms-21": "190.28",
"icms-22": "192.72",
"icms-23": "195.22",
"icms-17.5": "182.21",
"icms-19.5": "186.73",
"icms-20.5": "189.08",
"icms-22.5": "193.96",
"icms-12-alc": "168.77",
"icms-17-alc": "178.94",
"icms-18-alc": "181.12",
"icms-19-alc": "183.35",
"icms-20-alc": "185.65",
"icms-21-alc": "188.00",
"icms-22-alc": "190.41",
"icms-23-alc": "192.88",
"withoutTaxes": "148.52",
"icms-17.5-alc": "180.02",
"icms-19.5-alc": "184.49",
"icms-20.5-alc": "186.81",
"icms-22.5-alc": "191.63"
},
"pisCofinsList": "Positiva",
"substanceText": "HIDROCLOROTIAZIDA;VALSARTANA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "207.20",
"icms-12": "235.46",
"icms-17": "249.64",
"icms-18": "252.69",
"icms-19": "255.80",
"icms-20": "259.00",
"icms-21": "262.28",
"icms-22": "265.64",
"icms-23": "269.09",
"icms-17.5": "251.16",
"icms-19.5": "257.39",
"icms-20.5": "260.63",
"icms-22.5": "267.35",
"icms-12-alc": "233.31",
"icms-17-alc": "247.37",
"icms-18-alc": "250.39",
"icms-19-alc": "253.47",
"icms-20-alc": "256.65",
"icms-21-alc": "259.90",
"icms-22-alc": "263.23",
"icms-23-alc": "266.65",
"withoutTaxes": "205.31",
"icms-17.5-alc": "248.87",
"icms-19.5-alc": "255.05",
"icms-20.5-alc": "258.25",
"icms-22.5-alc": "264.92"
},
"invalidBarcodes": [],
"activeSubstances": [
"HIDROCLOROTIAZIDA",
"VALSARTANA"
],
"therapeuticClass": "C9D1 - ANTAGONISTAS DA ANGIOTENSINA II ASSOCIADOS A ANTIHIPERTENSIVOS (C2) E/OU DIURÉTICOS",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1356907320147",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "unknown",
"prescriptionRequired": null,
"therapeuticClassCode": "C9D1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:531620050087607"